recent publications
-
academic article
- Li, Y. X., O'Dell, S., Wilson, R., Wu, X., Schmidt, S. D., Hogerkorp, C. M., Louder, M. K., Longo, N. S., Poulsen, C., Guenaga, J., Chakrabarti, B. K., Doria-Rose, N., et al. Hiv-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins Journal of Virology 2012 86:11231-11241 DOI:10.1128/jvi.01543-12 PMID:22875963 PMCID:PMC3457177
- Wu, X. L., Zhou, T. Q., Zhu, J., Zhang, B. S., Georgiev, I., Wang, C., Chen, X. J., Longo, N. S., Louder, M., McKee, K., O'Dell, S., Perfetto, S., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science 2011 333:1593-1602 DOI:10.1126/science.1207532 PMID:21835983 PMCID:PMC3516815
- Wu, X. L., Yang, Z. Y., Li, Y. X., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T. Q., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1 Science 2010 329:856-861 DOI:10.1126/science.1187659 PMID:20616233 PMCID:PMC2965066
- Asabe, S., Wieland, S. F., Chattopadhyay, P. K., Roederer, M., Engle, R. E., Purcell, R. H., Chisari, F. V. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection Journal of Virology 2009 83:9652-9662 DOI:10.1128/jvi.00867-09 PMID:19625407 PMCID:PMC2748002
- Graham, B. S., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Martin, J. E., McCluskey, M. M., Chakrabarti, B. K., Lamoreaux, L., Andrews, C. A., Gomez, P. L., et al. Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 DNA candidate vaccine Journal of Infectious Diseases 2006 194:1650-1660 DOI:10.1086/509259 PMID:17109336 PMCID:PMC2428069
- Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B. T., Gall, J. G. D., et al. Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector Journal of Infectious Diseases 2006 194:1638-1649 DOI:10.1086/509258 PMID:17109335 PMCID:PMC2428071
- Martin, J. E., Sullivan, N. J., Enama, M. E., Gordon, I. J., Roederer, M., Koup, R. A., Bailer, R. T., Chakrabarti, B. K., Bailey, M. A., Gomez, P. L., Andrews, C. A., Moodie, Z., et al. A DNA vaccine for ebola virus is safe and immunogenic in a phase i clinical trial Clinical and Vaccine Immunology 2006 13:1267-1277 DOI:10.1128/cvi.00162-06 PMID:16988008